The mayo clinic approach to the surgical treatment of adenocarcinoma of the pancreas

Surgical Clinics of North America

Volumn 81, Issue 3, 2001, Pages 611-623

  Farnell, Michael B ^b   Nagorney, David M ^b   Sarr, Michael G ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL ANGIOGRAPHY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CONFERENCE PAPER; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; HUMAN; LAPAROSCOPY; LYMPHADENECTOMY; PANCREAS ADENOCARCINOMA; PANCREAS BIOPSY; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE;

EID: 0034969462     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70147-X     Document Type: Conference Paper

References (52)

1. Value of laparoscopic staging for upper gastrointestinal malignancies
2. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy
3. Lymph node involvement in carcinoma of the pancreas area
4. Venting intraluminal drains in pancreaticoduodenectomy
5. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma
6. Preoperative laparoscopy: Do we need it in patients with pancreatic malignancies?
7. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence
8. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
9. Diagnostic workup of patients with suspected pancreatic carcinoma: The University of California-Los Angeles approach
10. Isolated portal vein involvement in pancreatic adenocarcinoma: A contraindication for resection?
11. Is intra-abdominal drainage necessary after pancreaticoduodenectomy?
12. The role of laparoscopy in the management of suspected pancreatic and periampullary malignancies
13. Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreaticoduodenectomy?
14. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head
15. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection
16. Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion
17. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group
18. Preoperative endoscopic drainage for malignant obstructive jaundice
19. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head
20. Palliation of pain: Operation: Consensus statement
21. Palliative therapy for pancreatic cancer
22. Current status of surgical palliation of periampullary carcinoma
23. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease
24. Staging laparoscopy for pancreatic cancer should be used to select the best means of palliation and not only to maximize the resectability rate
25. Quality of life, nutritional status and gastrointestinal hormone profile following Whipple procedure
26. Complications following pancreaticoduodenectomy: Current management
27. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderated dose radiation and 5-fluorouracil, and high dose radiation and 5-fluorouracil: The Gastrointestinal Study Group
28. Pancreatic cancer
29. Long-term survival after resection for ductal adenocarcinoma of the pancreas: Is it really improving?
30. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas
31. Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy
32. Preoperative biliary drainage: Impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy
33. Comparison of preoperative serum CA 19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic gallbladder disease
34. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography: Comparison with conventional sonography, computed tomography, and angiography
35. Endoscopic ultrasonography in diagnosis and staging of pancreatic and biliary tumors
36. The role of laparoscopy in the preoperative staging of pancreatic carcinoma
37. Role of gastroenterostomy in patients with unresectable carcinoma of the pancreas
38. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas
39. Surgical palliation for pancreatic cancer
40. Radical pancreatoduodenectomy for misdiagnosed pancreatic mass
41. Aggressive surgery for pancreatic duct cell cancer: Feasibility, validity, limitations
42. Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer
43. An argument against routine percutaneous biopsy, ERCP, or biliary stent placement in patients with clinically resectable periampullary masses: A surgical perspective
44. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality
45. Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas
46. Radical pancreatoduodenectomy - A procedure to be abandoned?
47. Postoperative weight gain after standard Whipple's procedure versus pylorus-preserving pancreatoduodenectomy: The influence of tumour status
48. Preoperative staging and assessment of resectability of pancreatic cancer
49. Surgical palliation for pancreatic cancer: Developments during the past two decades
50. Palliation of pain in pancreatic cancer: Consensus statement
51. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients
52. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: Comparison of morbidity and mortality and short-term outcome